METFORMIN HYDROCHLORIDE tablet

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Buy It Now

Active ingredient:

METFORMIN HYDROCHLORIDE (UNII: 786Z46389E) (METFORMIN - UNII:9100L32L2N)

Available from:

direct rx

Administration route:

ORAL

Prescription type:

PRESCRIPTION DRUG

Therapeutic indications:

Metformin Hydrochloride Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. Metformin Hydrochloride Tablets are contraindicated in patients with: Severe renal impairment (eGFR below 30 mL/min/1.73 m2) [SEE WARNINGS AND PRECAUTIONS (5.1)]. Hypersensitivity to metformin. Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. 8.1 Pregnancy Risk Summary Limited data with Metformin Hydrochloride in pregnant women are not sufficient to determine a drug-associated risk for major birth defects or miscarriage. Published studies with metformin use during pregnancy have not reported a clear association with metformin and major birth defect or miscarriage risk [see Data]. There are risks to the mother and fetus associated with poorly controlled diabetes mellitus in pregnancy [see Clinical Considerations]. No adverse developmental effects were observed wh

Product summary:

16.1 How Supplied Table 13: Metformin Hydrochloride Tablets, USP Available Strengths, Units, and Appearance Metformin Hydrochloride Tablets, USP Metformin Hydrochloride Tablets, USP 500 mg are blackberry flavored, white to off-white, round, biconvex, beveled edge film coated tablets, debossed with ‘SG’ on one side ‘105’ on other side. Metformin Hydrochloride Tablets, USP 850 mg are blackberry flavored, white to off-white, round, biconvex, beveled edge film coated tablets, debossed with ‘SG’ on one side ‘106’ on other side. Metformin Hydrochloride Tablets, USP 1000 mg tablets are blackberry flavored, white to off-white, oval, biconvex, film coated tablets debossed on one side with S on the left side of bisect and G on the right side of bisect and other side 1 on the left side and 07 on the right side of the bisect. 16.2 Storage Store at 20°to 25°C (68°to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature.]

Authorization status:

Abbreviated New Drug Application

Summary of Product characteristics

                                METFORMIN HYDROCHLORIDE- METFORMIN HYDROCHLORIDE TABLET
DIRECT RX
----------
METFORMIN HYDROCHLORIDE
WARNING: LACTIC ACIDOSIS
Postmarketing cases of metformin-associated lactic acidosis have
resulted in
death, hypothermia, hypotension, and resistant bradyarrhythmias. The
onset of
metformin-associated lactic acidosis is often subtle, accompanied only
by
nonspecific symptoms such as malaise, myalgias, respiratory distress,
somnolence, and abdominal pain. Metformin-associated lactic acidosis
was
characterized by elevated blood lactate levels (>5 mmol/Liter), anion
gap acidosis
(without evidence of ketonuria or ketonemia), an increased
lactate/pyruvate ratio;
and metformin plasma levels generally >5 mcg/mL [SEE WARNINGS AND
PRECAUTIONS (5.1)].
Risk factors for metformin-associated lactic acidosis include renal
impairment,
concomitant use of certain drugs (e.g. carbonic anhydrase inhibitors
such as
topiramate), age 65 years old or greater, having a radiological study
with contrast,
surgery and other procedures, hypoxic states (e.g., acute congestive
heart
failure), excessive alcohol intake, and hepatic impairment.
Steps to reduce the risk of and manage metformin-associated lactic
acidosis in
these high risk groups are provided [SEE DOSAGE AND ADMINISTRATION
(2.3),
CONTRAINDICATIONS (4), WARNINGS AND PRECAUTIONS (5.1)].
If metformin-associated lactic acidosis is suspected, immediately
discontinue
metformin and institute general supportive measures in a hospital
setting. Prompt
hemodialysis is recommended [SEE WARNINGS AND PRECAUTIONS (5.1)].
Metformin Hydrochloride Tablets are indicated as an adjunct to diet
and exercise to
improve glycemic control in adults and pediatric patients 10 years of
age and older with
type 2 diabetes mellitus.
2.1 Adult Dosage
Metformin Hydrochloride Tablets
The recommended starting dose of Metformin Hydrochloride Tablets is
500 mg orally
twice a day or 850 mg once a day, given with meals.
Increase the dose in increments of 500 mg weekly or 850 mg every 2
weeks on the
basis of glycemic contro
                                
                                Read the complete document
                                
                            

Search alerts related to this product